For in vitro diagnostic use. Others Elecsys total PSA IVD Elecsys® total PSA CPS_000522 07027966190 Total PSA Elecsys E2G 300 Elecsys total PSA 04015630939824 Reagents, kits 300 tests cobas e 402/801 true 08791686190 Total PSA Elecsys cobas e 100 V3 Elecsys total PSA 07613336165959 Reagents, kits 100 tests cobas e 411/601/602 true 08791716190 Total PSA Elecsys cobas e 200 V2 Elecsys total PSA 07613336165973 Reagents, kits 200 tests cobas e 601/602 true 04491734190 Total PSA Elecsys cobas e 200 Elecsys total PSA 04015630936984 Reagents, kits 200 tests cobas e 601/602 true 08791732190 Total PSA Elecsys E2G 300 V2 Elecsys total PSA 07613336165980 Reagents, kits 300 tests cobas e 402/801 true 07027966500 Elecsys total PSA en 3 FF000000021C1D0E FF0000000175D40E 07027966190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThis assay, a quantitative in vitro diagnostic test for total (free + complexed) prostate‑specific antigen (tPSA) in human serum and plasma, is indicated for the measurement of total PSA in conjunction with digital rectal examination (DRE) as an aid in the detection of prostate cancer in men aged 50 years or older. Prostate biopsy is required for diagnosis of prostate cancer. The test is further indicated for serial measurement of tPSA to aid in the management of cancer patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 08791686500 Elecsys total PSA en 4 FF0000000669310E FF0000000356870E 08791686190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThis assay, a quantitative in vitro diagnostic test for total (free + complexed) prostate‑specific antigen (tPSA) in human serum and plasma, is indicated for the measurement of total PSA in conjunction with digital rectal examination (DRE) as an aid in the detection of prostate cancer in men aged 50 years or older. Prostate biopsy is required for diagnosis of prostate cancer. The test is further indicated for serial measurement of tPSA to aid in the management of cancer patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08791716500 Elecsys total PSA en 4 FF0000000669380E FF0000000356880E 08791716190 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThis assay, a quantitative in vitro diagnostic test for total (free + complexed) prostate‑specific antigen (tPSA) in human serum and plasma, is indicated for the measurement of total PSA in conjunction with digital rectal examination (DRE) as an aid in the detection of prostate cancer in men aged 50 years or older. Prostate biopsy is required for diagnosis of prostate cancer. The test is further indicated for serial measurement of tPSA to aid in the management of cancer patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e 601 and cobas e 602 immunoassay analyzers. en 04491734500 Elecsys total PSA en 7 FF00000005073C0E FF0000000036D10E 04491734190 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThis assay, a quantitative in vitro diagnostic test for total (free + complexed) prostate‑specific antigen (tPSA) in human serum and plasma, is indicated for the measurement of total PSA in conjunction with digital rectal examination (DRE) as an aid in the detection of prostate cancer in men aged 50 years or older. Prostate biopsy is required for diagnosis of prostate cancer. The test is further indicated for serial measurement of tPSA to aid in the management of cancer patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on MODULAR ANALYTICS E170, cobas e 601 and cobas e 602 immunoassay analyzers. en 08791732500 Elecsys total PSA en 5 FF000000053ED30E FF0000000402BB0E 08791732190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThis assay, a quantitative in vitro diagnostic test for total (free + complexed) prostate‑specific antigen (tPSA) in human serum and plasma, is indicated for the measurement of total PSA in conjunction with digital rectal examination (DRE) as an aid in the detection of prostate cancer in men aged 50 years or older. Prostate biopsy is required for diagnosis of prostate cancer. The test is further indicated for serial measurement of tPSA to aid in the management of cancer patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 08791732500 Elecsys total PSA en 7 FF00000006693B0E FF0000000402BA0E 08791732190 08791732214 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useThis assay, a quantitative in vitro diagnostic test for total (free + complexed) prostate‑specific antigen (tPSA) in human serum and plasma, is indicated for the measurement of total PSA in conjunction with digital rectal examination (DRE) as an aid in the detection of prostate cancer in men aged 50 years or older. Prostate biopsy is required for diagnosis of prostate cancer. The test is further indicated for serial measurement of tPSA to aid in the management of cancer patients.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en